Published February 6, 2023
| Version v1
Journal article
Open
Isoform- and ligand-specific modulation of the adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder
Description
Adhesion G protein-coupled receptors (aGPCRs) are cell-surface proteins with large extracellular regions that bind to multiple ligands to regulate key biological functions including neurodevelopment and organogenesis. Modulating a single function of a specific aGPCR isoform while affecting no other function and no other receptor is not trivial. Here, we engineered an antibody, termed LK30, that binds to the extracellular region of the aGPCR ADGRL3, and specifically acts as an agonist for ADGRL3 but not for its isoform, ADGRL1. The LK30/ADGRL3 complex structure revealed that the LK30 binding site on ADGRL3 overlaps with the binding site for an ADGRL3 ligand – teneurin. In cellular-adhesion assays, LK30 specifically broke the trans-cellular interaction of ADGRL3 with teneurin, but not with another ADGRL3 ligand – FLRT3. Our work provides proof of concept for the modulation of isoform- and ligand-specific aGPCR functions using unique tools, and thus establishes a foundation for the development of fine-tuned aGPCR-targeted therapeutics.
Data availability
The coordinates for the crystal structure of ADGRL3/LK30 generated in this study have been deposited in the Protein Data Bank [http://www.rcsb.org] under accession code PDB 8DJG. All the other relevant structures referenced in this work are available under the accession codes 6VHH, 4XWO, 5AFB, 5UCB, 6SKA and 5FTU. The authors declare that all data supporting the findings of this study are available within the article and the source data underlying Figs. 1b, g, 2a-c, 5e, j and Supplementary Figs. 4, 5 and 8 are provided as a Source Data file. The gating strategy for flow cytometry experiments can be found in Supplementary Fig. 10. Source data are provided with this paper.Files
Isoform-and-ligand-specific-modulation-of-the-adhesion-GPCR-ADGRL3-Latrophilin3-by-a-synthetic-binder.pdf
Files
(46.3 MB)
| Name | Size | Download all |
|---|---|---|
|
Supplementary information md5:6881b3c5a874a3ffb2f1218e6b8df69e |
22.4 MB | Preview Download |
|
Peer review file md5:85c7f40bb6f28b8ae7afdc9584a40793 |
3.4 MB | Preview Download |
|
Reporting summary md5:03f0f101e5d58f725e9a630f8f8cd5f5 |
275.6 kB | Preview Download |
|
Source data md5:2c2075bfcb1f87be05ebd9a14fcee71b |
17.5 MB | Download |
|
Article md5:68d48c0de5a6a18074b76cbdd074ebdd |
2.8 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1038/s41467-023-36312-7
- Other
- oai:uchicago.tind.io:5498
Funding
- National Institutes of Health
- R35 GM148412
- National Institutes of Health
- R01 GM134035-01
- National Institutes of Health
- F32 GM142266
- National Institutes of Health
- R01 GM117372
- National Cancer Institute
- ACB-12002
- National Institute of General Medical Sciences
- AGM-12006
- National Institute of General Medical Sciences
- P30GM138396
- United States Department of Energy
- DE-AC02-06CH11357
- National Institutes of Health
- S10 OD012289